Cardiology

There is a known connection between atrial fibrillation and stroke risk. Finding the best way to handle this connection can determine the success of care and the quality of life for patients.

Patients diagnosed with atrial fibrillation will often need treatment extending over a long period of time. In many cases ablation can be the best way to manage their symptoms requiring the work of an electrophysiologist.

The European Society of Cardiology's ESC Congress 2016 in Rome, Italy was huge, hot, and full of drama. Will any of the thousands of research reports delivered change practice?

There are many factors which can contribute to a patient developing Alzheimer's which goes beyond proteins which may be found in the brain.

Analysis of a large cohort group has found a significant connection between gut microbes and 2 of the largest risk factors for diabetes.

A new analysis of data published in JAMA Cardiology concludes that apixaban (Eliquis) tends to be both safer and more effective than warfarin in patients with atrial fibrillation, regardless of their renal function.

At The European Society of Cardiology Congress 2016 (ESC), Ibrahim Danad, MD, VU University Medical Center, Amsterdam, Netherlands, explained the results from his team's PACIFIC trial, which assessed two non-invasive coronary artery imaging tools: positon emission tomography (PET) and single photon emission computed tomography (SPECT).

Research suggests that lipid screening appears to remain particularly underutilized in adults taking antipsychotic medications, despite improvements in recent years in the use of diabetes screening in this patient population.

Thousands of cardiologists and other attendees at the ESC Congress 2016 got to meet Pope Francis, who told them he marveled at the science and human mystery of the heart.

About a quarter of patients who survived heart attacks due to blocked arteries could be treated with drugs, not invasive procedures. The trick is determining whether the blockage is cause by plaque erosion, not plaque rupture. With optical coherence tomography a team in Boston did just that.

At the European Society of Cardiology Congress 2016 (ESC) in Rome, Italy, Anselm Gitt, MD discussed the DYSIS program, which was designed to get an idea to see how patients were treated for secondary prevention, focusing on dyslipidemia patients.

The antiplatelet drugs prasugrel and ticagrelor are both fine for dual antiplatelet therapy following acute myocardial infarctions with ST segment elevations, a Czech study found.

Drug-eluting stents are falling far short of their promises of fewer complications, improved mortality and quality of life, a study found. In the largest study ever done comparing newer drug-eluting stents to bare metal devices, Norwegian researchers found the drug stents did not show a difference in these outcomes.

At the European Society of Cardiology Congress 2016 (ESC) in Rome, Italy, Chris Cannon, MD, Brigham & Women's Hospital, discussed the latest changes with the dyslipidemia guidelines.

The MD Magazine editors rounded up the 10 best stories from August – did you read them all?

Adding a PCSK9 inhibitor to apheresis therapy worked so well in reducing LDL in patients with familial hypercholesterolemia that two-thirds of the patients stopped getting apheresis.

At the European Society of Cardiology Congress 2016 (ESC) in Rome, Italy, Michael Lincoff, MD, Cleveland Clinic explained results from ACCELERATE trial involving patients with high risk vascular disease who received evacetrapib on top of standard care.

As one of the leading educational institutions on the island of Grenada, St. George's University plays a unique role not only in helping the students that come to the school to learn but also those who have already called the island home.

Whether medical students learn their craft at the most established institutions or newer schools around the world their ultimate goal is the same, to help the patient in front of them when they enter practice.

As an international university St. Geroge's can take their own route when it comes to preparing their students while still abiding by some of the traditions of other schools in the United States.

Located on the island of Grenada St. George's University has made a name for itself as one of the top international medical schools providing doctors to the United States.

Renato Delascio Lopes, MD, Duke University Medical Center, discussed at the European Society of Cardiology Congress 2016 (ESC), the progress of anticoagulant therapies for patients.

Victor Sandor, MD, Array BioPharma, shared results from ARRY 797 study at the European Society of Cardiology Congress 2016.

Should cardiac rehab be standard for patients who've had a heart attack. If so, how long should it last? A Dutch study found a year was about right.

Apheresis, the blood-filtering treatment used to remove cholesterol, appears to work for patients whose angina cannot be alleviated with drugs or surgical interventions researchers said today.

Simple preventive measures like reducing cholesterol and blood pressure should cut the risk of heart disease deaths and hospitalizations by up to 90%, an analysis found.

At the European Society of Cardiology Congress 2016 (ESC), Sigrun Halvorsen, MD, Oslo University discussed the results of her study which analyzed the bleeding rates among NVAF patients who were prescribed anticoagulants.

Christopher Granger, MD, professor of medicine, director of the Critical Care Unit at the Duke University Medical Center discussed that the European Society of Cardiology (ESC) has grown to be one of the best forums to discuss best practices of cardiovascular care.

Implantable cardioverter-defibrillators are not for all heart failure patients, the DANISH study found.

Experts at the European Society of Cardiology Congress 2016 (ESC) expressed varied opinions on the DANISH trial. Researchers presented that implantable cardioverter-defibrillators (ICDs) do not work for all heart patients.